Combine protein-ligand binding site analysis with in silico screening to identify 1) new druggable pockets on the protein 2) novel small molecule binders at the desired site.
Deliverables: Identification of binding sites, scoring and ranking of binding sites based on desired characteristics, ranked list of top 1000 selective drug like compounds, written report and presentation to client (x2 - 1 hour call)